BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Novel targeted therapies for cancer cachexia. Biochem J 2017;474:2663-78. [PMID: 28751550 DOI: 10.1042/BCJ20170032] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Liu A, Pan W, Zhuang S, Tang Y, Zhang H. Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. Adipocyte 2022;11:487-500. [PMID: 35941833 DOI: 10.1080/21623945.2022.2108558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang Y, An Z, Lin D, Jin W. Targeting cancer cachexia: Molecular mechanisms and clinical study. MedComm 2022;3. [DOI: 10.1002/mco2.164] [Reference Citation Analysis]
3 Wu H, Li S, Lin Y, Wang J, Chekhonin VP, Peltzer K, Baklaushev VP, Abbas KS, Zhang J, Li H, Zhang C. Association between malnutrition and leucopenia in patients with osteosarcoma. Front Nutr 2022;9:899501. [PMID: 35967822 DOI: 10.3389/fnut.2022.899501] [Reference Citation Analysis]
4 Ahmad SS, Ahmad K, Shaikh S, You HJ, Lee EY, Ali S, Lee EJ, Choi I. Molecular Mechanisms and Current Treatment Options for Cancer Cachexia. Cancers (Basel) 2022;14:2107. [PMID: 35565236 DOI: 10.3390/cancers14092107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Baghy K, Reszegi A, Horváth Z, Kovalszky I. The Role of Decorin in Cancer. The Extracellular Matrix and the Tumor Microenvironment 2022. [DOI: 10.1007/978-3-030-99708-3_2] [Reference Citation Analysis]
6 Giovanelli L, Quinton R. Therapeutic effects of androgens for cachexia. Best Pract Res Clin Endocrinol Metab 2021;:101598. [PMID: 34801415 DOI: 10.1016/j.beem.2021.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baba MR, Buch SA. Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches. Asia Pac J Oncol Nurs 2021;8:508-18. [PMID: 34527780 DOI: 10.4103/apjon.apjon-2126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kinoshita F, Tagawa T, Yamashita T, Takenaka T, Matsubara T, Toyokawa G, Takada K, Oba T, Osoegawa A, Yamazaki K, Takenoyama M, Shimokawa M, Nakashima N, Mori M. Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study. PLoS One 2021;16:e0256894. [PMID: 34473762 DOI: 10.1371/journal.pone.0256894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Campelj DG, Goodman CA, Rybalka E. Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. Cancers (Basel) 2021;13:3615. [PMID: 34298829 DOI: 10.3390/cancers13143615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
10 Zhou L, Zhang T, Shao W, Lu R, Wang L, Liu H, Jiang B, Li S, Zhuo H, Wang S, Li Q, Huang C, Lin D. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release. Skelet Muscle 2021;11:17. [PMID: 34229732 DOI: 10.1186/s13395-021-00274-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
11 Mannelli M, Gamberi T, Magherini F, Fiaschi T. A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes. Biomedicines 2021;9:698. [PMID: 34203023 DOI: 10.3390/biomedicines9060698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Takuya M, Akira K, Isao K, Shota N, Yoshihiro M, Kei G, Shiori M, Shingo K, Kiyomu F, Rina F, Hiroki K. Nutritional intervention for cancer sarcopenia. Ann Musculoskelet Med 2021. [DOI: 10.17352/amm.000024] [Reference Citation Analysis]
13 Eguren-santamaría I, Centeno C, Gil-bazo I. Cancer Cachexia. Practical Medical Oncology Textbook 2021. [DOI: 10.1007/978-3-030-56051-5_21] [Reference Citation Analysis]
14 Alves de Lima E Jr, Teixeira AAS, Biondo LA, Diniz TA, Silveira LS, Coletti D, Busquets Rius S, Rosa Neto JC. Exercise Reduces the Resumption of Tumor Growth and Proteolytic Pathways in the Skeletal Muscle of Mice Following Chemotherapy. Cancers (Basel) 2020;12:E3466. [PMID: 33233839 DOI: 10.3390/cancers12113466] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
15 Morigny P, Zuber J, Haid M, Kaltenecker D, Riols F, Lima JDC, Simoes E, Otoch JP, Schmidt SF, Herzig S, Adamski J, Seelaender M, Berriel Diaz M, Rohm M. High levels of modified ceramides are a defining feature of murine and human cancer cachexia. J Cachexia Sarcopenia Muscle 2020;11:1459-75. [PMID: 33090732 DOI: 10.1002/jcsm.12626] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
16 Hu Y, Gruber KA, Smith DE. Characterization of the cellular transport mechanisms for the anti-cachexia candidate compound TCMCB07. J Cachexia Sarcopenia Muscle 2020;11:1677-87. [PMID: 32725770 DOI: 10.1002/jcsm.12602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peixoto da Silva S, Santos JMO, Costa E Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle 2020;11:619-35. [PMID: 32142217 DOI: 10.1002/jcsm.12528] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 38.5] [Reference Citation Analysis]
18 Liva SG, Tseng YC, Dauki AM, Sovic MG, Vu T, Henderson SE, Kuo YC, Benedict JA, Zhang X, Remaily BC, Kulp SK, Campbell M, Bekaii-Saab T, Phelps MA, Chen CS, Coss CC. Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. EMBO Mol Med 2020;12:e9910. [PMID: 31930715 DOI: 10.15252/emmm.201809910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
19 Zwickl H, Zwickl-Traxler E, Pecherstorfer M. Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives. Front Oncol 2019;9:1409. [PMID: 31921666 DOI: 10.3389/fonc.2019.01409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Mori T, Ohmori H, Luo Y, Mori S, Miyagawa Y, Nukaga S, Goto K, Fujiwara-Tani R, Kishi S, Sasaki T, Fujii K, Kawahara I, Kuniyasu H. Giving combined medium-chain fatty acids and glucose protects against cancer-associated skeletal muscle atrophy. Cancer Sci 2019;110:3391-9. [PMID: 31432554 DOI: 10.1111/cas.14170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
21 Montalvo RN, Counts BR, Carson JA. Understanding sex differences in the regulation of cancer-induced muscle wasting. Curr Opin Support Palliat Care 2018;12:394-403. [PMID: 30102621 DOI: 10.1097/SPC.0000000000000380] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
22 Derksen JWG, Kurk SA, Oskam MJ, Peeters PHM, Punt CJA, Koopman M, May AM. Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer. JNCI Cancer Spectr. 2019;3:pkz014. [PMID: 31360897 DOI: 10.1093/jncics/pkz016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Minalyan A, Gabrielyan L, Pietra C, Taché Y, Wang L. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats. Front Integr Neurosci 2019;13:13. [PMID: 31031602 DOI: 10.3389/fnint.2019.00013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
24 Penna F, Ballarò R, Beltrà M, De Lucia S, García Castillo L, Costelli P. The Skeletal Muscle as an Active Player Against Cancer Cachexia. Front Physiol 2019;10:41. [PMID: 30833900 DOI: 10.3389/fphys.2019.00041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
25 Brown JC, Cespedes Feliciano EM, Caan BJ. The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers. J Cachexia Sarcopenia Muscle 2018;9:1200-8. [PMID: 30637983 DOI: 10.1002/jcsm.12379] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 24.7] [Reference Citation Analysis]
26 Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L; Precision Promise Consortium. Pancreas Cancer-Associated Weight Loss. Oncologist 2019;24:691-701. [PMID: 30591550 DOI: 10.1634/theoncologist.2018-0266] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 15.5] [Reference Citation Analysis]
27 Yakovenko A, Cameron M, Trevino JG. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia. World J Gastrointest Surg 2018; 10(9): 95-106 [PMID: 30622678 DOI: 10.4240/wjgs.v10.i9.95] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
28 Grisold W, Löscher W, Grisold A. Neurological complications of systemic tumor therapy. Wien Med Wochenschr 2019;169:33-40. [PMID: 30232660 DOI: 10.1007/s10354-018-0654-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Khatib MN, Shankar AH, Kirubakaran R, Gaidhane A, Gaidhane S, Simkhada P, Quazi Syed Z. Ghrelin for the management of cachexia associated with cancer. Cochrane Database Syst Rev. 2018;2:CD012229. [PMID: 29489032 DOI: 10.1002/14651858.cd012229.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
30 O'Sullivan S, Holzinger A, Wichmann D, Saldiva PHN, Sajid MI, Zatloukal K. Virtual autopsy: Machine Learning and AI provide new opportunities for investigating minimal tumor burden and therapy resistance by cancer patients. Autops Case Rep 2018;8:e2018003. [PMID: 29515978 DOI: 10.4322/acr.2018.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Penna F, Ballarò R, Beltrá M, De Lucia S, Costelli P. Modulating Metabolism to Improve Cancer-Induced Muscle Wasting. Oxid Med Cell Longev 2018;2018:7153610. [PMID: 29785246 DOI: 10.1155/2018/7153610] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]